Status post TACE RFA of a segment 5 lesion. Evaluate for residual or recurrent tumor. ABDOMEN:LIVER, BILIARY TRACT: Cirrhotic liver morphology and contour.The hepatic dome ablation zone measures 2.1 x 1.7 cm (series 801/369), unchanged.The peripheral segment 5/8 ablation zone measures 3.0 x 1.6 cm (series 801/289), compared to 2.8 x 1.5 cm previously.The segment 3 ablation zone measures 1.8 x 1.1 cm (series 801/189), compared to 1.7 x 1.4 cm previously.The new segment 5 ablation zone measures 3.1 x 1.2 cm (series 801/174). No residual enhancing lesion.No new arterial enhancing lesion or other discrete mass lesion. Trace perihepatic ascites, unchanged.Normally distended gallbladder. No biliary ductal dilatation.SPLEEN: The spleen measures 10.4 cm in craniocaudal dimension.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Simple right renal inferior pole cyst.RETROPERITONEUM, LYMPH NODES: Infrarenal abdominal aortic aneurysm is partially imaged measuring 4.2 x 4.4 cm (series 601/1) in maximal cross-section with asymmetric mural thrombus. It measures 4.5 cm in transverse dimension on the coronal images. BOWEL, MESENTERY: Colonic diverticulosis.BONES, SOFT TISSUES: Fluid and peripheral enhancement without restricted diffusion in the right lower anterior chest wall soft tissues along the recent RFA tract.OTHER: No significant abnormality noted.
1.Interval TACE/RFA of the segment 5 lesion without evidence of residual or recurrent tumor. Relatively stable bilobar ablation zones without evidence of tumor recurrence.2.Cirrhosis with no new new suspicious liver lesion.3.Fluid and peripheral enhancement of new RFA tract; correlate for signs and symptoms of infection. 4.Partially evaluated infrarenal abdominal aortic aneurysm. 